Patent ID: 8192749
Filing Date: 2012-06-05
Classification: A61K,A61P

Abstract:
1. A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human an antibiotic tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea, wherein the antibiotic tetracycline compound is selected from the group consisting of: a 20 mg dose of doxycycline administered twice a day, a 40 mg dose of doxycycline administered by sustained release over a 24 hour period, a 38 mg dose of minocycline administered once a day, a 60 mg dose of tetracycline administered once a day, a 60 mg dose of tetracycline administered twice a day, a 60 mg dose of tetracycline administered three times a day, and a 60 mg dose of tetracycline administered four times a day, wherein the antibiotic tetracycline compound is administered in an amount which results in a serum concentration which is 10-80% of the minimum antibiotic serum concentration.